Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nevus, Epithelioid and Spindle Cell | 2 | 2025 | 14 | 1.100 |
Why?
|
| Skin Neoplasms | 5 | 2025 | 849 | 0.990 |
Why?
|
| Tripartite Motif Proteins | 3 | 2025 | 39 | 0.980 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2025 | 192 | 0.880 |
Why?
|
| Alopecia Areata | 1 | 2025 | 13 | 0.870 |
Why?
|
| Hypohidrosis | 1 | 2021 | 3 | 0.700 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 25 | 0.580 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 107 | 0.570 |
Why?
|
| Transcription Factors | 3 | 2025 | 1734 | 0.550 |
Why?
|
| Mastectomy | 1 | 2019 | 184 | 0.530 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 2382 | 0.240 |
Why?
|
| Skin Care | 1 | 2025 | 22 | 0.220 |
Why?
|
| Hair Follicle | 1 | 2025 | 49 | 0.220 |
Why?
|
| Non-Fibrillar Collagens | 1 | 2024 | 3 | 0.220 |
Why?
|
| Pemphigoid, Bullous | 1 | 2024 | 7 | 0.210 |
Why?
|
| Phototherapy | 1 | 2024 | 49 | 0.210 |
Why?
|
| Tubular Sweat Gland Adenomas | 1 | 2022 | 1 | 0.190 |
Why?
|
| Sweat Gland Diseases | 1 | 2022 | 2 | 0.190 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2022 | 8 | 0.190 |
Why?
|
| Nevus | 1 | 2022 | 26 | 0.190 |
Why?
|
| Hamartoma | 1 | 2022 | 29 | 0.180 |
Why?
|
| Autoantigens | 1 | 2024 | 427 | 0.170 |
Why?
|
| Hypopigmentation | 1 | 2021 | 3 | 0.170 |
Why?
|
| Nail Diseases | 1 | 2021 | 9 | 0.170 |
Why?
|
| Child | 6 | 2025 | 22707 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2025 | 666 | 0.160 |
Why?
|
| Melanoma | 1 | 2024 | 759 | 0.130 |
Why?
|
| Cytokines | 1 | 2025 | 2067 | 0.130 |
Why?
|
| Adolescent | 4 | 2025 | 22530 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2024 | 1509 | 0.120 |
Why?
|
| Prognosis | 1 | 2025 | 4316 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1266 | 0.120 |
Why?
|
| Humans | 12 | 2025 | 145475 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2025 | 11853 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2025 | 5216 | 0.080 |
Why?
|
| Male | 5 | 2025 | 72843 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 2664 | 0.080 |
Why?
|
| Female | 5 | 2025 | 78845 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2025 | 6447 | 0.070 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2024 | 1 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 26 | 0.050 |
Why?
|
| Infant, Extremely Premature | 1 | 2025 | 68 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2024 | 117 | 0.050 |
Why?
|
| Liver Failure, Acute | 1 | 2024 | 68 | 0.050 |
Why?
|
| Sweat Glands | 1 | 2022 | 5 | 0.050 |
Why?
|
| CME-Carbodiimide | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2022 | 30 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 848 | 0.040 |
Why?
|
| Melanocytes | 1 | 2022 | 65 | 0.040 |
Why?
|
| Nails | 1 | 2021 | 14 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2025 | 619 | 0.040 |
Why?
|
| Adult | 1 | 2019 | 40777 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1321 | 0.030 |
Why?
|
| Infant | 1 | 2024 | 10077 | 0.020 |
Why?
|